Login to MyKarger

New to MyKarger? Click here to sign up.

Login with Facebook

Forgot Password? Reset your password

Authors, Editors, Reviewers

For Manuscript Submission, Check or Review Login please go to Submission Websites List.

Submission Websites List

Institutional Login (Shibboleth)

For the academic login, please select your country in the dropdown list. You will be redirected to verify your credentials.

Table of Contents
Vol. 36, No. 2, 2011
Issue release date: April 2011
Section title: Review
Free Access
Neuroepidemiology 2011;36:109–120

Stress as a Risk Factor for Multiple Sclerosis Onset or Relapse: A Systematic Review

Artemiadis A.K.a, b · Anagnostouli M.C.a · Alexopoulos E.C.b
aImmunogenetic Laboratory, Department of Neurology, Aeginition Hospital, and bStress Management and Health Promotion, National and Kapodistrian University Medical School, Athens, Greece
email Corresponding Author

Artemios K. Artemiadis, MD, MSc

Immunogenetic Laboratory, Department of Neurology, Aeginition Hospital

National and Kapodistrian University Medical School

Vassilisis Sofias Avenue 72–74, GR–115-28 Athens (Greece)

Tel. +30 210 728 9165, E-Mail artemiad@med.uoa.gr


  1. Casetta I, Granieri E: Prognosis of multiple sclerosis: environmental factors. Neurol Sci 2000;21(4 suppl 2):S839–S842.
    External Resources
  2. Coo H, Aronson KJ: A systematic review of several potential non-genetic risk factors for multiple sclerosis. Neuroepidemiology 2004;23:1–12.
  3. Charcot JM: Lectures on the Diseases of the Nervous System. London, New Sydenham Society, 1877.
  4. Goodin DS, Ebers GC, Johnson KP, Rodriguez M, Sibley WA, Wolinsky JS: The relationship of MS to physical trauma and psychological stress: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1999;52:1737–1745.
  5. Mohr DC, Hart SL, Julian L, Cox D, Pelletier D: Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis. BMJ 2004;328:731.
  6. Chrousos GP: Stress and disorders of the stress system. Nat Rev Endocrinol 2009;5:374–381.
  7. Goldstein DS, McEwen B: Allostasis, homeostats, and the nature of stress. Stress 2002;5:55–58.
  8. McEwen BS: Stress, adaptation, and disease: allostasis and allostatic load. Ann NY Acad Sci 1998;840:33–44.
  9. Chrousos GP: Stressors, stress, and neuroendocrine integration of the adaptive response. The 1997 Hans Selye Memorial Lecture. Ann NY Acad Sci 1998;851:311–335.
  10. Hellhammer DH, Wüst S, Kudielka BM: Salivary cortisol as a biomarker in stress research. Psychoneuroendocrinology 2009;34:163–171.
  11. Cohen S, Kessler RC: Measuring Stress. Oxford, Oxford University Press, 1997.
  12. Mitsonis CI, Potagas C, Zervas I, Sfagos K: The effects of stressful life events on the course of multiple sclerosis: a review. Int J Neurosci 2009;119:315–335.
  13. Mohr DC: Stress and multiple sclerosis. J Neurol 2007;254(suppl 2):II65–II68.
  14. Mohr DC, Pelletier D: A temporal framework for understanding the effects of stressful life events on inflammation in patients with multiple sclerosis. Brain Behav Immun 2006;20:27–36.
  15. Brown RF, Tennant CC, Dunn SM, Pollard JD: A review of stress-relapse interactions in multiple sclerosis: important features and stress-mediating and -moderating variables. Mult Scler 2005;11:477–484.
  16. Artemiadis AK, Anagnostouli MC: Apoptosis of oligodendrocytes and post-translational modifications of myelin basic protein in multiple sclerosis: possible role for the early stages of multiple sclerosis. Eur Neurol 2010;63:65–72.
  17. Wells GA, Shea B, O’Connell D, Peterson J, Welch V, Losos M, Tugwell P: The Newcastle-Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses. Ottawa, Ottawa Health Research Institute, 1999.
  18. Flachenecker P: Epidemiology of neuroimmunological diseases. J Neurol 2006;253 (suppl 5):V2–V8.
  19. Held U, Heigenhauser L, Shang C, Kappos L, Polman C, Sylvia Lawry Centre for MS Research: Predictors of relapse rate in MS clinical trials. Neurology 2005;65:1769–1773.
  20. Thompson AJ, Miller D, Youl B, MacManus D, Moore S, Kingsley D, Kendall B, Feinstein A, McDonald WI: Serial gadolinium-enhanced MRI in relapsing/remitting multiple sclerosis of varying disease duration. Neurology 1992;42:60–63.
  21. Yamout B, Itani S, Hourany R, Sibaii AM, Yaghi S: The effect of war stress on multiple sclerosis exacerbations and radiological disease activity. J Neurol Sci 2010;288:42–44.
  22. Somer E, Golan D, Dishon S, Cuzin-Disegni L, Lavi I, Miller A: Patients with multiple sclerosis in a war zone: coping strategies associated with reduced risk for relapse. Mult Scler 2010;16:463–471.
  23. Liu XJ, Ye HX, Li WP, Dai R, Chen D, Jin M: Relationship between psychosocial factors and onset of multiple sclerosis. Eur Neurol 2009;62:130–136.
  24. Hellwig K, Schimrigk S, Beste C, Muller T, Gold R: Increase in relapse rate during assisted reproduction technique in patients with multiple sclerosis. Eur Neurol 2009;61:65–68.
  25. Golan D, Somer E, Dishon S, Cuzin-Disegni L, Miller A: Impact of exposure to war stress on exacerbations of multiple sclerosis. Ann Neurol 2008;64:143–148.
  26. Mitsonis CI, Zervas IM, Mitropoulos PA, Dimopoulos NP, Soldatos CR, Potagas CM, Sfagos CA: The impact of stressful life events on risk of relapse in women with multiple sclerosis: a prospective study. Eur Psychiatry 2008;23:497–504.
  27. Potagas C, Mitsonis C, Watier L, Dellatolas G, Retziou A, Mitropoulos P, Sfagos C, Vassilopoulos D: Influence of anxiety and reported stressful life events on relapses in multiple sclerosis: a prospective study. Mult Scler 2008;14:1262–1268.
  28. Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD: Relationship between stress and relapse in multiple sclerosis. Part 1. Important features. Mult Scler 2006;12:453–464.
  29. Brown RF, Tennant CC, Sharrock M, Hodgkinson S, Dunn SM, Pollard JD: Relationship between stress and relapse in multiple sclerosis. Part 2. Direct and indirect relationships. Mult Scler 2006;12:465–475.
  30. Li J, Johansen C, Brønnum-Hansen H, Stenager E, Koch-Henriksen N, Olsen J: The risk of multiple sclerosis in bereaved parents: a nationwide cohort study in Denmark. Neurology 2004;62:726–729.
  31. Simmons RD, Ponsonby AL, van der Mei IA, Sheridan P: What affects your MS? Responses to an anonymous, Internet-based epidemiological survey. Mult Scler 2004;10:202–211.
  32. Ackerman KD, Stover A, Heyman R, Anderson BP, Houck PR, Frank E, Rabin BS, Baum A: 2002 Robert Ader New Investigator award. Relationship of cardiovascular reactivity, stressful life events, and multiple sclerosis disease activity. Brain Behav Immun 2003;17:141–151.
  33. Buljevac D, Hop WC, Reedeker W, Janssens AC, van der Meché FG, van Doorn PA, Hintzen RQ: Self reported stressful life events and exacerbations in multiple sclerosis: prospective study. BMJ 2003;327:646.
  34. Ackerman KD, Heyman R, Rabin BS, Anderson BP, Houck PR, Frank E, Baum A: Stressful life events precede exacerbations of multiple sclerosis. Psychosom Med 2002;64:916–920.
  35. Mohr DC, Goodkin DE, Nelson S, Cox D, Weiner M: Moderating effects of coping on the relationship between stress and the development of new brain lesions in multiple sclerosis. Psychosom Med 2002;64:803–809.
  36. Mohr DC, Goodkin DE, Bacchetti P, Boudewyn AC, Huang L, Marrietta P, Cheuk W, Dee B: Psychological stress and the subsequent appearance of new brain MRI lesions in MS. Neurology 2000;55:55–61.
  37. Kroencke DC, Denney DR: Stress and coping in multiple sclerosis: exacerbation, remission and chronic subgroups. Mult Scler 1999;5:89–93.
  38. Schwartz CE, Foley FW, Rao SM, Bernardin LJ, Lee H, Genderson MW: Stress and course of disease in multiple sclerosis. Behav Med 1999;25:110–116.
  39. Palumbo R, Fontanillas L, Salmaggi A, la Mantia L, Milanese C: Stressful life events and multiple sclerosis: a retrospective study. Ital J Neurol Sci 1998;19:259–260.
  40. Gasperini C, Grasso MG, Fiorelli M, Millefiorini E, Morino S, Anzini A, Colleluori A, Salvetti M, Buttinelli C, Pozzilli C: A controlled study of potential risk factors preceding exacerbation in multiple sclerosis. J Neurol Neurosurg Psychiatry 1995;59:303–305.
  41. Morrison W, Nelson J: Environmental triggers in multiple sclerosis: fact or fallacy? Axone 1994;16:23–26.
  42. Nisipeanu P, Korczyn AD: Psychological stress as risk factor for exacerbations in multiple sclerosis. Neurology 1993;43:1311–1312.
  43. Warren S, Warren KG, Cockerill R: Emotional stress and coping in multiple sclerosis (MS) exacerbations. J Psychosom Res 1991;35:37–47.
  44. Grant I, Brown GW, Harris T, McDonald WI, Patterson T, Trimble MR: Severely threatening events and marked life difficulties preceding onset or exacerbation of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989;52:8–13.
  45. Warren S, Greenhill S, Warren KG: Emotional stress and the development of multiple sclerosis: case-control evidence of a relationship. J Chronic Dis 1982;35:821–831.
  46. Warren SA, Warren KG, Greenhill S, Paterson M: How multiple sclerosis is related to animal illness, stress and diabetes. Can Med Assoc J 1982;126:377–382, 385.
  47. Heesen C, Gold SM, Huitinga I, Reul JM: Stress and hypothalamic-pituitary-adrenal axis function in experimental autoimmune encephalomyelitis and multiple sclerosis: a review. Psychoneuroendocrinology 2007;32:604–618.
  48. Dhabhar FS: Enhancing versus suppressive effects of stress on immune function: implications for immunoprotection and immunopathology. Neuroimmunomodulation 2009;16:300–317.
  49. Gold SM, Mohr DC, Huitinga I, Flachenecker P, Sternberg EM, Heesen C: The role of stress-response systems for the pathogenesis and progression of MS. Trends Immunol 2005;26:644–652.
  50. Zorzon M, de Masi R, Nasuelli D, Ukmar M, Mucelli RP, Cazzato G, Bratina A, Zivadinov R: Depression and anxiety in multiple sclerosis: a clinical and MRI study in 95 subjects. J Neurol 2001;248:416–421.
  51. Fassbender K, Schmidt R, Mössner R, Kischka U, Kühnen J, Schwartz A, Hennerici M: Mood disorders and dysfunction of the hypothalamic-pituitary-adrenal axis in multiple sclerosis: association with cerebral inflammation. Arch Neurol 1998;55:66–72.
  52. Pakenham KI: Making sense of illness or disability: the nature of sense making in multiple sclerosis (MS). J Health Psychol 2008;13:93–105.
  53. D’Souza M, Kappos L, Czaplinski A: Reconsidering clinical outcomes in multiple sclerosis: relapses, impairment, disability and beyond. J Neurol Sci 2008;274:76–79.
  54. Li DK, Li MJ, Traboulsee A, Zhao G, Riddehough A, Paty D: The use of MRI as an outcome measure in clinical trials. Adv Neurol 2006;98:203–226.
    External Resources
  55. Cotton F, Weiner HL, Jolesz FA, Guttmann CR: MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals. Neurology 2003;60:640–646.
  56. Lee MA, Smith S, Palace J, Matthews PM: Defining multiple sclerosis disease activity using MRI T2-weighted difference imaging. Brain 1998;121:2095–2102.
  57. Filippi M: Linking structural, metabolic and functional changes in multiple sclerosis. Eur J Neurol 2001;8:291–297.
  58. Barnett MH, Prineas JW: Relapsing and remitting multiple sclerosis: pathology of the newly forming lesion. Ann Neurol 2004;55:458–468.
  59. Alonso G: Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and gray matter regions of the brain. Glia 2000;31:219–231.
  60. Khorchid A, Fragoso G, Shore G, Almazan G: Catecholamine-induced oligodendrocyte cell death in culture is developmentally regulated and involves free radical generation and differential activation of caspase-3. Glia 2002;40:283–299.
  61. Zhang LX, Levine S, Dent G, Zhan Y, Xing G, Okimoto D, Kathleen Gordon M, Post RM, Smith MA: Maternal deprivation increases cell death in the infant rat brain. Brain Res Dev Brain Res 2002;133:1–11.
  62. Butts BD, Houde C, Mehmet H: Maturation-dependent sensitivity of oligodendrocyte lineage cells to apoptosis: implications for normal development and disease. Cell Death Differ 2008;15:1178–1186.